TY - JOUR
T1 - Bronchial Thermoplasty. A Novel Therapy for Severe Asthma.
AU - Sheshadri, Ajay
AU - Castro, Mario
AU - Chen, Alexander
N1 - Funding Information:
Disclosures: A. Sheshadri has no professional or financial interests to disclose. A. Chen has lectured for Asthmatx/Boston Scientific. M. Castro served as consultant or on the advisory board for Genentech, IPS, Medimmune, NKT Therapeutics, and Schering. He lectured for Asthmax/Boston Scientific, Boehringer Ingelheim, Genentech, GSK, Merck, and Pfizer. His University received industry-sponsored grants from Amgen , Asthmatx/Boston Scientific , Ception/Cephalon , Genentech , GSK , Kalbios , MedImmune , Merck , Novartis , and Sanofi-Aventis . His University received grant monies from the NIH and the ALA and received royalties from Elsevier .
PY - 2013/9
Y1 - 2013/9
N2 - This article presents an overview of bronchial thermoplasty, a novel treatment for severe asthma. Within, the authors discuss the rationale for bronchial thermoplasty in severe asthma, current clinical evidence for the use of this procedure, clinical recommendations, and future directions.
AB - This article presents an overview of bronchial thermoplasty, a novel treatment for severe asthma. Within, the authors discuss the rationale for bronchial thermoplasty in severe asthma, current clinical evidence for the use of this procedure, clinical recommendations, and future directions.
KW - Airway remodeling
KW - Airway smooth muscle
KW - Bronchial thermoplasty
KW - Severe asthma
UR - http://www.scopus.com/inward/record.url?scp=84883050074&partnerID=8YFLogxK
U2 - 10.1016/j.ccm.2013.03.003
DO - 10.1016/j.ccm.2013.03.003
M3 - Review article
C2 - 23993815
AN - SCOPUS:84883050074
SN - 0272-5231
VL - 34
SP - 437
EP - 444
JO - Clinics in Chest Medicine
JF - Clinics in Chest Medicine
IS - 3
ER -